Akeso, Inc. (HKG:9926)
Hong Kong
· Delayed Price · Currency is HKD 92.50
-2.35 (-2.48%)
Jun 27, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 83.03 billion as of June 27, 2025. Its market cap has increased by 117.93% in one year.
Market Cap
83.03B
Enterprise Value
79.35B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
92.50
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 83.03B, an increase of 347.72%. That is a compound annual growth rate of 33.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 85.14B | 56.26% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 237.03B |
| Hansoh Pharmaceutical Group Company | 173.02B |
| JD Health International | 135.68B |
| Innovent Biologics | 129.81B |
| WuXi Biologics | 101.72B |
| Sino Biopharmaceutical | 92.46B |
| CSPC Pharmaceutical Group | 89.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 74.28B |